This bill prohibits the Federal Aviation Administration from setting a requirement that air carriers and foreign air carriers must require a passenger to test negative for COVID-19 to travel domestically on such carriers.
Impact
If passed, HB 103 would significantly impact public health policy as it pertains to air travel within the United States. It effectively reinforces the idea that the federal government should not impose COVID-19 related testing requirements across the aviation sector. This could lead to an increase in passenger volume as many travelers may feel more comfortable flying without the fear of being subjected to testing protocols. Furthermore, it could set a precedent influencing how transportation policies are shaped in future public health emergencies.
Summary
House Bill 103, introduced by Mr. Biggs, aims to preclude the Secretary of Transportation and the Federal Aviation Administration (FAA) from mandating COVID-19 testing for individuals traveling by air on domestic flights. The bill reflects a growing pushback against pandemic-related mandates, specifically the testing requirements that have been a subject of contention within the airline industry. By removing the authority to impose such requirements, the bill seeks to restore a level of normalcy to air travel, allowing for a more streamlined process without additional health-related protocols.
Contention
Notable points of contention surrounding HB 103 include the balance between public health and personal freedom. Proponents argue that passengers should not be required to undergo testing to travel, thus protecting individual rights and enabling economic recovery within the aviation sector. In contrast, opponents may raise concerns about the potential implications for public health, especially in contexts where new variants of COVID-19 are emerging. The debate reflects broader tensions regarding the role of government in personal health decisions and the ongoing socio-political discussions around COVID-19 management.
This bill prohibits any entity that receives specified COVID-19 relief funds from mandating COVID-19 vaccines for its employees. An entity that violates this prohibition must return the funding it received.
Protecting Businesses From Frivolous COVID Lawsuits Act of 2023 This bill requires a specific jury instruction in a federal civil action for damages based on negligence arising from the transmission of COVID-19. Specifically, a court must instruct the jury that negligence may not be found solely on the basis of holding oneself open for business.